Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

Kristina R. Chacko; Paul J. Gaglio

doi:10.1016/j.cld.2015.06.002

Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

Kristina R. Chacko, Paul J. Gaglio

Medicine

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

Original language	English (US)
Pages (from-to)	605-617
Number of pages	13
Journal	Clinics in Liver Disease
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/j.cld.2015.06.002
State	Published - Nov 2015

Keywords

Direct-acting antiviral agents
NS5A inhibitors
Polymerase inhibitors
Protease inhibitors

ASJC Scopus subject areas

Hepatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cld.2015.06.002

Cite this

@article{b8640f217a09489991b96592c653a9c6,

title = "Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.",

abstract = "This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.",

keywords = "Direct-acting antiviral agents, NS5A inhibitors, Polymerase inhibitors, Protease inhibitors",

author = "Chacko, {Kristina R.} and Gaglio, {Paul J.}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = nov,

doi = "10.1016/j.cld.2015.06.002",

language = "English (US)",

volume = "19",

pages = "605--617",

journal = "Clinics in Liver Disease",

issn = "1089-3261",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

AU - Chacko, Kristina R.

AU - Gaglio, Paul J.

PY - 2015/11

Y1 - 2015/11

N2 - This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

AB - This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.

KW - Direct-acting antiviral agents

KW - NS5A inhibitors

KW - Polymerase inhibitors

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84943583020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943583020&partnerID=8YFLogxK

U2 - 10.1016/j.cld.2015.06.002

DO - 10.1016/j.cld.2015.06.002

M3 - Review article

C2 - 26466650

AN - SCOPUS:84943583020

SN - 1089-3261

VL - 19

SP - 605

EP - 617

JO - Clinics in Liver Disease

JF - Clinics in Liver Disease

IS - 4

ER -

Meet the Classes of Directly Acting Antiviral Agents. Strengths and Weaknesses.

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this